RxDoctor Payments Data

Tram Tran, DO

Family Medicine · Pearland, TXNPI 1811336589

Payments from drug & device makers

$3,425in general payments, 2019–2025

Across 193 payments — averaging $17.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$797
  • Lilly USA, LLC$541
  • AstraZeneca$428
  • Pfizer$410
  • Merck$235
  • Abbott$202
  • plus $810 from 20 others

What the payments were for

  • Food & beverage$3,419100%
  • Education$60%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,425 in reported general payments places this provider in the 80th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$36,326
Medicare patients
112
Services billed
369

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin72$108,077
OzempicSemaglutide50$67,513
EliquisApixaban36$41,862
JanuviaSitagliptin Phosphate29$29,048
MounjaroTirzepatide14$16,394
VascepaIcosapent Ethyl15$12,346
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog14$7,692
Rosuvastatin Calcium162$3,642
Lantus SolostarInsulin Glargine,hum.Rec.Anlog23$2,811
Levothyroxine Sodium176$2,102
Atorvastatin Calcium237$2,015
Losartan Potassium188$1,847
Metformin Hcl ErMetformin Hcl149$1,321
Gabapentin96$1,279
SynthroidLevothyroxine Sodium19$1,276

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$14$108,07772 claims
Novo NordiskOzempic$797$67,51350 claims
PfizerEliquis$410$41,86236 claims
MerckJanuvia$235$29,04829 claims
Lilly USA, LLCMounjaro$541$16,39414 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$29$2,102176 claims
AbbVieSynthroid$43$1,27619 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Pearland

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →